X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2797) 2797
Book Review (378) 378
Publication (246) 246
Conference Proceeding (99) 99
Book Chapter (91) 91
Dissertation (14) 14
Government Document (2) 2
Journal / eJournal (2) 2
Paper (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ssri (2320) 2320
index medicus (1583) 1583
humans (1167) 1167
psychiatry (941) 941
male (894) 894
depression (829) 829
female (809) 809
neurosciences (735) 735
pharmacology & pharmacy (727) 727
antidepressants (667) 667
serotonin (583) 583
adult (546) 546
fluoxetine (505) 505
serotonin uptake inhibitors - therapeutic use (501) 501
animals (492) 492
serotonin uptake inhibitors (456) 456
middle aged (406) 406
serotonin uptake inhibitors - pharmacology (359) 359
antidepressant (353) 353
clinical neurology (353) 353
paroxetine (327) 327
serotonin reuptake inhibitors (317) 317
serotonin uptake inhibitors - adverse effects (297) 297
major depression (295) 295
citalopram (284) 284
double-blind (258) 258
treatment outcome (256) 256
anxiety (253) 253
rats (248) 248
antidepressive agents - therapeutic use (244) 244
aged (230) 230
major depressive disorder (226) 226
depression, mental (220) 220
adolescent (216) 216
selective serotonin reuptake inhibitor (215) 215
depressive disorder - drug therapy (208) 208
sertraline (208) 208
analysis (201) 201
depressive disorder, major - drug therapy (194) 194
pregnancy (171) 171
article (170) 170
drug therapy (169) 169
depression - drug therapy (162) 162
dose-response relationship, drug (154) 154
double-blind method (153) 153
serotonin uptake inhibitors - administration & dosage (150) 150
brain (145) 145
phenols (144) 144
5-ht (142) 142
mice (142) 142
snri (141) 141
efficacy (135) 135
serotonin - metabolism (134) 134
young adult (133) 133
antidepressive agents - adverse effects (131) 131
citalopram - pharmacology (129) 129
risk factors (129) 129
escitalopram (128) 128
fluvoxamine (126) 126
fluoxetine - pharmacology (125) 125
citalopram - therapeutic use (123) 123
risk (121) 121
rats, sprague-dawley (118) 118
mental depression (117) 117
psychiatric status rating scales (116) 116
selective serotonin reuptake inhibitors (115) 115
time factors (113) 113
antidepressive agents - pharmacology (111) 111
care and treatment (111) 111
drugs (108) 108
mental disorders (106) 106
obsessive-compulsive disorder (105) 105
serotonin transporter (102) 102
antidepressive agents, second-generation - therapeutic use (101) 101
child (101) 101
research (99) 99
brain - drug effects (97) 97
placebo-controlled trial (97) 97
children (90) 90
behavioral sciences (89) 89
psychopharmacology (88) 88
health aspects (87) 87
psychology (87) 87
treatment (87) 87
neurology (85) 85
disorder (84) 84
pharmacotherapy (84) 84
reuptake inhibitors (84) 84
stress (84) 84
dopamine (83) 83
pharmacology (83) 83
fluoxetine - therapeutic use (81) 81
panic disorder (81) 81
behavior, animal - drug effects (80) 80
drug therapy, combination (79) 79
pediatrics (79) 79
rat-brain (75) 75
behavior (74) 74
placebo (74) 74
psychotherapy (74) 74
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2597) 2597
German (122) 122
Japanese (50) 50
French (39) 39
Italian (30) 30
Spanish (30) 30
Swedish (28) 28
Czech (26) 26
Turkish (19) 19
Polish (9) 9
Dutch (6) 6
Portuguese (5) 5
Hungarian (4) 4
Russian (3) 3
Chinese (2) 2
Croatian (1) 1
Korean (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The use of SSRI (Selective Serotonin Reuptake Inhibitors) in kleptomania’s treatment: case reports, 12/2004
Kleptomania is characterized by a recurrent failure to resist the impulse to steal objects not necessary for personal use or their monetary value. Although... 
kleptomania, pharmacological treatment, SSRI | Psychiatry
Journal
Study of the antinociceptive activity of fluoxetine and its interaction with morphine and naloxone in mice, 11/2004
OBJECTIVE: To study the probable site of the antinociceptive action of fluoxetine and its interaction with morphine and naloxone. MATERIAL AND METHODS: The... 
Pharmacology | Analgesia, SSRI, opioids ph04131
Journal
Annals of Clinical Psychiatry, ISSN 1040-1237, 9/2002, Volume 14, Issue 3, pp. 143 - 147
Despite the superior side effect profile of the newer antidepressants over the tricyclics and monoamine oxidase inhibitors, all newer antidepressants are... 
SSRI-induced agitation | Neurology | SSRI-associated weight gain | SSRI-induced sexual dysfunction | Medicine & Public Health | Psychopharmacology | prescribing practices | SSRI-associated side effects | side effects | SSRI-inducedinsomnia | Psychiatry | Side effects | Prescribing practices | SSRI-induced insomnia
Journal Article
Journal of the American Osteopathic Association, ISSN 0098-6151, 02/2019, Volume 119, Issue 2, pp. 102 - 111
Selective serotonin reuptake inhibitors (SSRIs) are among the most commonly prescribed medications in the United States. Although SSRIs are highly tolerable... 
Ssri | Selective serotonin reuptake inhibitor
Journal Article
Journal of Pediatric Surgery, ISSN 0022-3468, 2019
Purpose: Hirschsprung disease (HSCR) is a multifactorial disease. Maternal intake of selective serotonin reuptake inhibitors (SSRI) during early pregnancy has... 
SSRI | Epidemiology | Hirschsprung disease | Maternal risk factor
Journal Article
Biology of Reproduction, ISSN 0006-3363, 2015, Volume 93, Issue 4
ABSTRACT Selective serotonin reuptake inhibitors (SSRIs) are widely used antidepressants for the treatment of depression. However, SSRIs cause sexual side... 
SSRI | gonadotropins | 5-HT | testes | reproduction
Journal Article
Revue Medicale de Bruxelles, ISSN 0035-3639, 05/2018, Volume 39, Issue 3, pp. 181 - 184
Journal Article
Encephale, ISSN 0013-7006, 06/2018, Volume 44, Issue 3, pp. 291 - 296
Introduction: Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) are frequently prescribed. These... 
SSRI | Hyponatremia | Pharmacoepidemiological study | SNRI
Journal Article
COMPREHENSIVE PSYCHIATRY, ISSN 0010-440X, 01/2014, Volume 55, Issue 1, pp. 1 - 10
Aims: Apathy in the context of treated major depressive disorder (MDD) is a frequently observed phenomenon in clinical practice. This study aimed to assess the... 
SSRI | PSYCHIATRY | RELIABILITY | SCALE | QUESTIONNAIRE | VALIDITY
Journal Article
Journal of Palliative Medicine, ISSN 1096-6218, 05/2019, Volume 22, Issue 5, pp. 572 - 579
Palliative care (PC) providers often prescribe psychotropic medications to address psychological and physical suffering of patients with serious medical... 
Palliative Care Specialists Series
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 11/2005, Volume 19, Issue 6, pp. 567 - 596
These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the... 
Antipsychotics | Anticonvulsants | Cognitive behaviour therapy | Evidence-based guidelines | Generalized anxiety disorder | Antidepressants | Anxiety disorders | Panic disorder | Obsessive-compulsive disorder | Anxiolytics | Benzodiazepines | treatment | POSTTRAUMATIC-STRESS-DISORDER | post-traumatic stress disorder | social phobia | obsessive-compulsive disorder | RANDOMIZED CONTROLLED-TRIAL | INTERNATIONAL CONSENSUS GROUP | CLINICAL NEUROLOGY | SEROTONIN REUPTAKE INHIBITORS | simple phobia | venlafaxine | cognitive behaviour therapy | generalized anxiety disorder | COGNITIVE-BEHAVIORAL THERAPY | antipsychotics | NATIONAL-COMORBIDITY-SURVEY | PHARMACOLOGY & PHARMACY | benzodiazepines | PSYCHIATRY | anxiolytics | evidence-based guidelines | antidepressants | anxiety disorders | NEUROSCIENCES | GENERALIZED SOCIAL PHOBIA | SSRI | PLACEBO-CONTROLLED TRIAL | anticonvulsants | LONG-TERM TREATMENT | panic disorder | Behavior Therapy | Humans | Middle Aged | Breast Feeding | Anxiety Disorders - diagnosis | Child, Preschool | Anxiety Disorders - epidemiology | Male | Treatment Outcome | Combined Modality Therapy | Evidence-Based Medicine | Psychotropic Drugs - therapeutic use | Antidepressive Agents - therapeutic use | Pregnancy | Psychotropic Drugs - adverse effects | Adolescent | Adult | Anti-Anxiety Agents - adverse effects | Female | Aged | Anti-Anxiety Agents - therapeutic use | Antidepressive Agents - adverse effects | Anxiety Disorders - drug therapy | Care and treatment | Anxiety | Diagnosis | Psychopharmacology | Standards | Pharmacology | Drug therapy | Anxieties | Evidence-based medicine | Guidelines | Index Medicus
Journal Article
Biological psychiatry, ISSN 0006-3223, 7/2016, Volume 80, Issue 1, pp. 33 - 39
Journal Article
European Psychiatry, ISSN 0924-9338, 01/2018, Volume 47, pp. 49 - 49
Journal Article
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 10/2016, Volume 36, Issue 6, pp. 726 - 728
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, pp. e0165122 - e0165122
Background Hypothesised associations between in utero exposure to selective serotonin reuptake inhibitors (SSRIs) and congenital anomalies, particularly... 
UNITED-STATES | PRIMARY-CARE | PRENATAL EXPOSURE | LOW-BIRTH-WEIGHT | HEART-DEFECTS | MULTIDISCIPLINARY SCIENCES | CARDIAC-MALFORMATIONS | POPULATION-BASED COHORT | MATERNAL DEPRESSION | PRETERM BIRTH | PERSISTENT PULMONARY-HYPERTENSION | Heart Defects, Congenital - chemically induced | Abnormalities, Drug-Induced - epidemiology | Humans | Serotonin Uptake Inhibitors - therapeutic use | Wales | Serotonin Uptake Inhibitors - adverse effects | Depressive Disorder - drug therapy | Pregnancy Complications - physiopathology | Abnormalities, Drug-Induced - physiopathology | Pregnancy Complications - drug therapy | Antidepressive Agents - therapeutic use | Pregnancy | Depressive Disorder - complications | Norway | Denmark | Heart Defects, Congenital - epidemiology | Adult | Female | Heart Defects, Congenital - physiopathology | Antidepressive Agents - adverse effects | Depressive Disorder - epidemiology | Pregnancy Complications - epidemiology | Databases, Factual | Complications and side effects | Prognosis | Depression, Mental | Serotonin uptake inhibitors | Congenital heart disease | Dosage and administration | Research | Drug therapy | Risk factors | Health care | Congenital defects | Systematic review | Mental depression | Data bases | Defects | Teratogenesis | Confidence intervals | Databases | Antidepressants | Suicides & suicide attempts | Significance | Public health | Congenital diseases | Statistical analysis | Menstruation | Serotonin | Fetuses | Exposure | Regression analysis | Intrauterine exposure | Studies | Population (statistical) | Womens health | Congenital anomalies | Teratogenicity | Health risk assessment | Index Medicus
Journal Article
INDIAN JOURNAL OF PSYCHIATRY, ISSN 0019-5545, 01/2019, Volume 61, Issue 9, pp. S532 - S532
Conference Proceeding
INDIAN JOURNAL OF PSYCHIATRY, ISSN 0019-5545, 01/2017, Volume 59, Issue 6, pp. S247 - S247
Conference Proceeding